Tumor infiltrating lymphocytes in lymph node metastases of stage III melanoma as a predictor for response and survival in patients treated with ipilimumab when progressing to stage IV
Explore related products in the following collection:
Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by clicking here.